98 related articles for article (PubMed ID: 25219251)
1. [Effects of Survivin-T34A mutant on breast cancer cell in vitro and in vivo].
Deng X; Song H; Ren M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Jun; 31(3):648-51. PubMed ID: 25219251
[TBL] [Abstract][Full Text] [Related]
2. [Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].
Pan L; Peng XC; Yuan QZ; Leng F; Yu DD; Shan Y; Li ZY; Wang CT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):390-3. PubMed ID: 20629305
[TBL] [Abstract][Full Text] [Related]
3. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
4. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1.
Ma X; Zhang Y; Kang Y; Li L; Zheng W
Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.
Zhang L; Gao X; Men K; Wang B; Zhang S; Qiu J; Huang M; Gou M; Huang N; Qian Z; Zhao X; Wei Y
Int J Nanomedicine; 2011; 6():2419-27. PubMed ID: 22072877
[TBL] [Abstract][Full Text] [Related]
6. [Influence of human epithelial ovarian cancer HO-8910 cells with modified survivin gene on the cell cycle distribution and chemosensitivity].
Peng LP; Huang JM; Zhang GN; Zha X; Ren Y; Fan Y; Deng BF
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):860-4. PubMed ID: 21211287
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
[TBL] [Abstract][Full Text] [Related]
9. Self-Assembled Nanoparticle Mediated
Xiao Y; Wang C; Xiong M; Yang Y; Zhang Q; Liu X; Zou B; Gou M
J Biomed Nanotechnol; 2018 Dec; 14(12):2092-2101. PubMed ID: 30305216
[TBL] [Abstract][Full Text] [Related]
10. Cancer gene therapy using a survivin mutant adenovirus.
Mesri M; Wall NR; Li J; Kim RW; Altieri DC
J Clin Invest; 2001 Oct; 108(7):981-90. PubMed ID: 11581299
[TBL] [Abstract][Full Text] [Related]
11. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
McKay TR; Bell S; Tenev T; Stoll V; Lopes R; Lemoine NR; McNeish IA
Oncogene; 2003 Jun; 22(23):3539-47. PubMed ID: 12789262
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.
Pan L; Peng XC; Leng F; Yuan QZ; Shan Y; Yu DD; Li ZY; Chen X; Xiao WJ; Wen Y; Ma TT; Yang L; Mao YQ; Yang HS; Wei YQ; Wang CT
J Cancer Res Clin Oncol; 2011 Jan; 137(1):19-28. PubMed ID: 20217127
[TBL] [Abstract][Full Text] [Related]
13. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
Xue Z; Sun PH; Zhu LM; Jiang SH; Qiao MM; Chi AL; Tu SP
Oncol Rep; 2011 Apr; 25(4):1039-46. PubMed ID: 21279308
[TBL] [Abstract][Full Text] [Related]
15. [Effects of survivin antisense RNA and HSP70 double gene transfection on MCF-7 cells in vitro].
Gong DY; Guo TT; Fu HX; Peng Y; Wang XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1587-9. PubMed ID: 20650773
[TBL] [Abstract][Full Text] [Related]
16. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition Function of Dominant-negative Mutant Gene Survivin-D53A to SPC-A1 Lung Adenocarcinoma Xenograft in Nude Mice Models].
Yu M; Peng X; Lu Y; Huang M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):624-8. PubMed ID: 26485989
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli.
Tsai SL; Chang YC; Sarvagalla S; Wang S; Coumar MS; Cheung CHA
Protein Expr Purif; 2019 Aug; 160():73-83. PubMed ID: 31004782
[TBL] [Abstract][Full Text] [Related]
19. [Suppressing the growth of Hep-2 human laryngeal cancer cells by silencing survivin gene in vitro and in vivo].
Wen LJ; Gao LF; Ji K; Zhang HJ; Fu DN; Yang JP; Xu YP; Chen GW; Jin CS; Zhao XJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):674-9. PubMed ID: 21055246
[TBL] [Abstract][Full Text] [Related]
20. [Effects of siRNA targeted to survivin in suppressing proliferation and inducing apoptosis in breast cancer MCF-7 cells].
Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):326-30. PubMed ID: 17044992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
